You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.
The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.
Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.
In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.
The US Senate has unanimously passed a $2 trillion stimulus package to address the coronavirus, the New York Times reports.
The White House earlier this week announced a supercomputer consortium to uncover or develop drugs to address the COVID-19 pandemic, according to NPR.
The Los Angeles Times writes that another coronavirus testing challenge — antibody testing — looms.
In Nature this week: single-cell transcriptomic data to map human tissue, combined genomic and machine learning approach for non-invasive early lung cancer screening, and more.
The Washington Post reports the US Senate is to vote on a $2 trillion coronavirus stimulus package today.
Bloomberg writes that Fred Hutchinson Cancer Research Center's Trevor Bedford and his colleagues continue to use viral genomics to track SARS-CoV-2.
A woman's ability to smell differences between people with and without Parkinson's disease could someday lead to a tool to detect the condition early, according to NPR.
In Cell this week: analyses of SARS-CoV-2 interactions with human receptors and mouse pancreas cells that could form organoids.
The US Food and Drug Administration has issued a safety alert for fecal microbiota transplants as SARS-CoV-2 has been found in patients' stool.
Mother Jones reports scammers are pretending to be from the CDC to sell COVID-19 tests.
Researchers find through imaging that the tongue microbiome is highly structured, Science reports.
In PNAS this week: interactions of coronavirus' EndoU endoribonuclease enzyme, analysis of phylogenetic trees, and more.
Nature News reports that some geneticists are concerned that they only learned from a colleague's tweet that they might have been exposed to SARS-CoV-2.
The UK is launching a research consortium to sequence SARS-CoV-2 samples from patients.
In PLOS this week: yeast modeling of mutations found through MSKCC IMPACT, tumor features associated with presence of circulating DNA, and more.
ScienceInsider reports that academic groups in the US are pushing for additional research support to deal with disruptions brought on by the pandemic.
According to the Washington Post, an NIH researcher has been stymied in getting an exemption to use fetal tissue to study possible COVID-19 treatments.
New Scientist writes that researchers have genetically modified nerve cells to produce electrically functional polymers.
In Science this week: sequencing of diverse human genomes gives insight into genetic variation and population history, commentary on data sharing, and more.
The Economist writes that two kinds of testing are important to control the spread of COVID-19.
A testing startup plans to launch an at-home COVID-19 test, Time reports.